市場調查報告書
商品編碼
1603798
生物醫學感測器的全球市場預測(-2030):按產品類型、感測器類型、連接性、應用、最終用戶和區域進行分析Biomedical Sensor Market Forecasts to 2030 - Global Analysis By Product Type, Sensor Type, Connectivity, Application, End User and By Geography |
根據Stratistics MRC預測,2024年全球生物醫學感測器市場規模預計將達到107億美元,2030年將達到178億美元,預測期內複合年成長率為8.8%。
生物醫學感測器是透過檢測和測量體溫、血壓、心率和血糖濃度等生物訊號和參數來監測人類健康的設備。這些感測器透過將生理資料轉換為電訊號進行分析,有助於疾病診斷、治療監測和患者護理。穿戴式科技、診斷工具和醫療植入都使用生物醫學感測器來提供即時健康監測,並實現量身定做的醫療干預措施,以獲得更好的結果。
根據世界衛生組織 (WHO) 統計,2021 年,心血管疾病和糖尿病等慢性疾病影響了全球約 5.37 億成年人。
對病患監測的需求增加
慢性病的流行和人口老化增加了對病患監測系統的需求。生物醫學感測器能夠持續即時監測生命徵象和其他健康參數,從而能夠及早發現並及時干預健康問題。這一趨勢正在推動生物醫學感測器在醫療保健和居家照護環境中的採用,從而推動市場成長。
安全問題
生物醫學感測器與連接設備和網路的整合引起了對資料安全和患者隱私的擔憂。未授權存取敏感醫療資訊可能會導致洩漏機密和資料濫用。此類安全風險可能會阻礙生物醫學感測器的廣泛採用,特別是在醫療機構和注重隱私的個人中,從而抑制市場成長。
醫療保健支出增加
全球醫療保健支出的成長對於生物醫學感測器市場來說是一個巨大的機會。隨著政府和私營部門增加對醫療保健基礎設施和先進醫療技術的投資,對包含生物醫學感測器的先進監測和診斷工具的需求預計將會增加。這種趨勢在醫療保健系統正在快速現代化的新興國家尤其明顯。
醫療保健監管的變化
生物醫學感測器市場面臨著不斷發展的醫療法規和標準的潛在威脅。對包括感測器在內的醫療設備的嚴格監管要求可能會導致產品開發週期更長和成本更高。此外,報銷政策的變化可能會影響醫療保健環境中基於感測器的技術的採用。這些監管不確定性給市場相關人員帶來了挑戰,並可能影響成長軌跡。
COVID-19 大流行對生物醫學感測器市場產生了重大影響。最初,供應鏈中斷和製造業放緩造成了暫時的挫折。然而,疫情加速了遠端患者監護解決方案和遠端醫療服務的採用,推動了對生物醫學感測器的需求。在醫院和家庭護理環境中持續監測患者生命徵象的需求進一步推動了市場成長。長期影響包括個人健康監測意識的提高以及向預防性醫療保健的轉變,從而使生物醫學感測器市場受益。
非侵入式感測器領域預計將在預測期內成為最大的領域
由於其卓越的患者舒適度和易用性,預計非侵入式感測器領域將在預測期內獲得最大的市場佔有率。這些感測器可以在不破壞皮膚或進入體腔的情況下監測各種生理參數,使其成為連續監測和家庭醫療保健應用的理想選擇。與侵入式感測器相比,非侵入式感測器還可以降低感染和併發症的風險。對微創醫療程序的日益偏好以及穿戴式健康設備的日益普及正在推動這一領域的主導地位。
生物分析感測器領域預計在預測期內複合年成長率最高
預計生物分析感測器領域將在預測期內顯著成長。這些感測器旨在檢測和測量體內特定的生物或化學物質,具有高靈敏度和選擇性。對個人化醫療、照護現場診斷和各種疾病生物標記持續監測的日益關注正在推動對生物分析感測器的需求。此外,奈米技術和材料科學的進步正在增強這些感測器的功能,從而可以對複雜的生物樣品進行快速、準確且經濟高效的分析。
預計在預測期內,北美將佔據生物醫學感測器市場的最大佔有率。這一優勢歸因於多種因素,包括先進的醫療基礎設施、高昂的醫療成本以及早期採用創新醫療技術。該地區擁有許多領先的醫療設備製造商和研究機構,為感測器技術的持續創新做出了貢獻。此外,慢性病的高盛行率和人口老化正在推動對採用生物醫學感測器的先進病患監測解決方案的需求。
亞太地區預計將在生物醫學感測器市場實現最高的複合年成長率。中國和印度等國家的快速經濟成長、醫療保健支出的增加以及醫療保健基礎設施的改善正在推動市場擴張。該地區龐大且不斷成長的人口以及預防保健意識的不斷增強正在為生物醫學感測器創造一個巨大的市場。此外,旨在實現醫療保健系統現代化和增加數位醫療技術採用的政府措施也促進了該地區市場的高成長率。
According to Stratistics MRC, the Global Biomedical Sensor Market is accounted for $10.7 billion in 2024 and is expected to reach $17.8 billion by 2030, growing at a CAGR of 8.8% during the forecast period. A biomedical sensor is a device used to monitor a person's health by detecting and measuring biological signals or parameters, such as temperature, blood pressure, heart rate, or glucose levels. These sensors help with disease diagnosis, treatment monitoring, and patient care by converting physiological data into electrical signals for analysis. Wearable technology, diagnostic tools, and medical implants all use biomedical sensors to provide real-time health monitoring and enable tailored medical interventions for better results.
According to the World Health Organization (WHO), chronic diseases such as cardiovascular diseases and diabetes affected approximately 537 million adults globally in 2021.
Increased demand for patient monitoring
The growing prevalence of chronic diseases and an aging population have led to increased demand for patient monitoring systems. Biomedical sensors enable continuous, real-time monitoring of vital signs and other health parameters, allowing for early detection of health issues and timely interventions. This trend is driving the adoption of biomedical sensors in healthcare settings and home care environments, fueling market growth.
Security concerns
The integration of biomedical sensors with connected devices and networks raises concerns about data security and patient privacy. Unauthorized access to sensitive health information could lead to breaches of confidentiality and potential misuse of data. These security risks may hinder the widespread adoption of biomedical sensors, particularly in healthcare institutions and among privacy-conscious individuals, thus restraining market growth.
Growing healthcare expenditure
Increasing healthcare expenditure worldwide presents a significant opportunity for the biomedical sensors market. As governments and private sectors invest more in healthcare infrastructure and advanced medical technologies, the demand for sophisticated monitoring and diagnostic tools incorporating biomedical sensors is expected to rise. This trend is particularly pronounced in emerging economies, where healthcare systems are rapidly modernizing.
Changes in healthcare regulations
The biomedical sensors market faces potential threats from evolving healthcare regulations and standards. Stringent regulatory requirements for medical devices, including sensors, can lead to longer product development cycles and increased costs. Additionally, changes in reimbursement policies may affect the adoption of sensor-based technologies in healthcare settings. These regulatory uncertainties could pose challenges to market players and impact growth trajectories.
The COVID-19 pandemic significantly impacted the biomedical sensors market. Initially, supply chain disruptions and manufacturing slowdowns caused temporary setbacks. However, the pandemic also accelerated the adoption of remote patient monitoring solutions and telehealth services, driving demand for biomedical sensors. The need for continuous monitoring of COVID-19 patients' vital signs in hospitals and home care settings further boosted market growth. Long-term effects include increased awareness of personal health monitoring and a shift towards preventive healthcare, benefiting the biomedical sensors market.
The non-invasive sensors segment is expected to be the largest during the forecast period
The non-invasive sensors segment is predicted to secure the largest market share throughout the forecast period due to their advantages in patient comfort and ease of use. These sensors can monitor various physiological parameters without breaking the skin or entering body cavities, making them ideal for continuous monitoring and home healthcare applications. Non-invasive sensors also offer reduced risk of infection and complications compared to invasive alternatives. The growing preference for minimally invasive medical procedures and the increasing adoption of wearable health devices contribute to this segment's dominance.
The bioanalytic sensors segment is expected to have the highest CAGR during the forecast period
The bioanalytic sensors segment is projected to witness substantial growth during the projection period. These sensors are designed to detect and measure specific biological or chemical substances in the body, offering high sensitivity and selectivity. The increasing focus on personalized medicine, point-of-care diagnostics, and continuous monitoring of biomarkers for various diseases drives the demand for bioanalytic sensors. Furthermore, advancements in nanotechnology and materials science are enhancing the capabilities of these sensors, enabling rapid, accurate, and cost-effective analysis of complex biological samples.
North America is expected to hold the largest share in the biomedical sensors market during the forecast period. This dominance is attributed to several factors, including advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative medical technologies. The region's strong presence of leading medical device manufacturers and research institutions contributes to continuous innovation in sensor technologies. Additionally, the high prevalence of chronic diseases and an aging population drive the demand for advanced patient monitoring solutions incorporating biomedical sensors.
The Asia Pacific region is projected to achieve the highest CAGR in the biomedical sensors market. Rapid economic growth, increasing healthcare expenditure, and improving healthcare infrastructure in countries like China and India are driving market expansion. The region's large and growing population, coupled with rising awareness of preventive healthcare, creates a substantial market for biomedical sensors. Additionally, government initiatives to modernize healthcare systems and the increasing adoption of digital health technologies further contribute to the region's high growth rate in the market.
Key players in the market
Some of the key players in Biomedical Sensor Market include GE Healthcare, Analog Devices, Inc., STMicroelectronics N.V., Medtronic PLC, NXP Semiconductor N.V., Honeywell International Inc., Texas Instruments, Nonin Medical Inc., First Sensor AG, Smiths Medical, Measurement Specialties, Inc., LumaSense Technologies, Zephyr Technology Corp., Innovative Sensor Technology USA, and Amphenol Corporation.
In October 2024, Medtronic has introduced the Nellcor(TM) OxySoft(TM) SpO2 sensor, which uses silicone adhesive to protect fragile skin and improve repositionability. This sensor is designed for critical care patients and provides continuous oxygen saturation monitoring.
In April 2024, Nonin Medical has partnered with Medixine to integrate pulse oximetry devices into a digital remote patient monitoring platform. This collaboration aims to streamline overnight oxygen therapy pre-screening using Nonin's wearable devices.
In January 2024, Amphenol has expanded its sensor portfolio through acquisitions of companies like LID (pressure sensors) and PCTEL (wireless technology). These acquisitions will enhance Amphenol's offerings in medical sensor technologies.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.